LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Phase 2

Completed

• Conditions: Lung Cancer; Cancer of Lung; Cancer of the Lung; Non-Small Cell Lung Carcinoma; Carcinoma, Non-Small Cell Lung
• Interventions: Drug: YM155

• Registration Number: NCT00328588
• Lead Sponsor: Astellas Pharma Inc

Brief Summary

A study for the treatment of Non-Small Cell Lung Cancer (NSCLC) in patients previously treated with chemotherapy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-05-19
• Study First Submitted QC: 2006-05-19
• Study First Posted: 2006-05-22
• Study Start: 2006-12
• Primary Completion: 2007-03
• Study Completion: 2007-03
• Status Verified: 2007-12
• Last Update Submitted: 2007-12-26
• Last Update Posted: 2008-01-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

• Histologically or cytologically confirmed non-small cell lung cancer.
• Prior chemotherapy regimen(s) for lung cancer

Exclusion Criteria

• History of other malignancy in the last 5 years
• Major surgery within the past 21 days

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	YM155	7 days continuous infusion

Primary Outcome Measures

Name	Time	Method
Tumor response rate (CR+PR)	In first 6 cycles